Interferon (IFN)
Structures bearing major histocompatibility complex (MHC) 1 -related molecules play an important role in cellular immunity, recognition, and differentiation (1, 2) . The MHC class II (MHC-II) genes, composed of HLA-DR, -DQ, -DP, and -DM, encode ␣ and ␤ chains of heterodimeric cell surface molecules that present processed antigens to CD4 ϩ T-lymphocytes. In contrast to MHC class I (MHC-I) molecules that are expressed on virtually all cell surfaces, constitutive MHC-II expression is restricted to only a few cell types, classically Blymphocytes, thymic epithelial cells, dendritic cells, and macrophages. However, other cell types such as type 1 astrocytes, vascular endothelial and smooth muscle cells, and fibroblasts can express MHC-II in response to interferon (IFN)-␥, interleukin (IL)-4, and IL-10 (3-5). Indeed, the induction of MHC-II on endothelial cells was the first reported example of "endothelial activation" (4) , defined as the appearance of novel gene products on the endothelial cell surface, which allow endothelial cells to perform new functions (6) . Endothelial MHC-II expression was found on the endothelium in atherosclerotic lesions obtained from patients who died of cardiovascular or neurologic diseases (7) , and the induction of MHC-II on vascular wall cells, in part, mediates the cellular immune response associated with transplantation arteriosclerosis (8) . Moreover, a recent clinical study found increased expression of MHC-II molecules in arterial tissue from transplanted hearts to be predictive of arteriosclerosis and graft failure (9) .
Besides expressing MHC-II, cytokine-activated endothelial cells express various other cell surface adhesion molecules such as vascular and intercellular adhesion molecules, VCAM-1 and ICAM-1, which allow binding of mononuclear cells to the vessel wall. The signaling pathways leading to the induction of VCAM-1 and ICAM-1 expression involves the activation of oxidant-sensitive proinflammatory transcription factors, nuclear factor-B (NF-B), and activated protein-1 (10, 11) . Indeed, antioxidants such as N-acetylcysteine (NAC) and pyrrolidine dithiocarbamate (PDTC) have been shown to inhibit NF-B activation and cytokine-induced endothelial cell activation (10) . Furthermore, we have shown recently (12, 13) that another endogenous ROS, nitric oxide (NO), can attenuate cytokine-induced VCAM-1 and macrophage-colony-stimulating factor gene transcription via stabilization and induction of the NF-B inhibitor, IB␣. However, it is not known whether the induction of MHC-II is under similar redox control since its minimal promoter (Ϫ136 bp to ϩ31 bp), which is required for full response to IFN-␥, does not contain B or activated protein-1 cis-acting elements (14) .
The upstream regions of all MHC-II genes contain conserved DNA elements, called W, X, and Y, which are essential for full transcriptional activation (2, 15) . Contained in the Y box is a CCAAT motif that interacts with the constitutively expressed heterotrimeric transcription factor NF-Y. The DNA binding activity of NF-Y resides in the specific association of three nonidentical A, B, and C subunits (16, 17) . The CCAAT motif resembles the oxyR-response element of prokaryotic cells, which is known to mediate redox-dependent transcriptional activation of bacterial genes coding for peroxide-inactivating enzymes such as catalase (katG), NADPH-dependent alkylhydroperoxidase (aphFC), and others (18, 19) . Previous studies have indicated that the oxyR-response element can also function as a redox-dependent transcriptional activator in mammalian cells (20) and that NF-Y itself is regulated by cellular redox (21) .
Although it is known that stimulation of endothelial cells with IFN-␥ induces the generation of superoxide anion (O 2 . ), it
is not known whether the production of ROS is necessary and/or sufficient for MHC-II gene transcription (22) . The purpose of this study, therefore, was to determine the role of ROS in mediating MHC-II gene transcription in vascular endothelial cells.
SDS, and 250 g/ml salmon sperm DNA. All Northern blots were subjected to stringent washing conditions (0.2ϫ SSC, 0.1% SDS at 65°C) before autoradiography with an intensifying screen for 24 h to 72 h at Ϫ80°C. Western Blotting-Nuclear extracts were diluted 1:2 with Laemmli Sample buffer (Bio-Rad), boiled for 5 min, and centrifuged for 2 min at 14,000 ϫ g. Protein concentration was determined with the Micro BCA Protein Assay (Pierce). Samples (15 g of protein) were separated by SDS-PAGE (10% running, 4% stacking). The separated proteins were electrophoretically transferred to nitrocellulose membranes with 0.45-m pore size from Osmonics (Westborough, MA) using the Mini Trans-Blot Cell (Bio-Rad). The blots were blocked for 1 h at room temperature in PBS buffer (containing 0.1% Tween 20 and 5% nonfat milk), before incubation with the primary antibody (anti-NF-Y A or anti-NF-Y B , Rockland Inc., Gilbertsville, PA) overnight at 4°C. After washing the membranes four times in PBS with Tween 20 buffer, a peroxidase-conjugated secondary antibody (anti-rabbit IgG, Rockland Inc., 1:4000) was added for 45 min. Immunodetection was accomplished using the Renaissance chemiluminescence kit (PerkinElmer Life Sciences).
Fluorescent Measurement of Intracellular Oxidation-HSVEC of less than three passages were cultured in 35-mm dishes (Corning Glass) coated with 0.1% gelatin. Phenol-free M199 medium ϩ 15 mM Hepes (pH 7.4) was used. Before seeding the endothelial cells, a sterile coverslip was placed on the bottom of each dish. To subtract background fluorescent activity from intracellular fluorescence, these coverslips were eliminated before measurement in order to have a cell-free control field. Intracellular generation of reactive oxygen species (ROS) was quantified using DCFH-DA (Amersham Biosciences). This esterified form is cell membrane-permeable and undergoes deacetylation by intracellular esterases. Upon oxidation, DCFH is converted to dichlorofluoroscein (DCF), a fluorescent compound. Confluent endothelial cell monolayers were incubated 30 min with 30 M DCFH-DA before stimulation with the indicated substances. Fluorescence was monitored under 5% CO 2 at 37°C using an inverted microscope (Zeiss Axiovert 405 M, Oberkochen, Germany). A mercury lamp with a 490-nm filter was used as a light source for excitation. Excitation time (3 s) was constant for all conditions. Emission wavelength was set to 525 nm. Images were acquired using a CCD camera (Photometrics CH 250, Tucson, AZ) with a 512 ϫ 512 pixel format. Analysis was performed with ISEE software version 3.6 (Inovision, Durham, NC) from six different representative fields for each condition in each experiment. Background fluorescence activity (cell-free area) was subtracted.
Nuclear Run-on Assay-Confluent endothelial cells (ϳ10 8 cells) were stimulated with IFN-␥ (1000 units/ml) alone or in combination with GSNO (0.2 mM) for 24 h. Cells were subsequently washed twice with PBS, trypsinized, and centrifuged at 300 ϫ g for 5 min at 4°C. The cellular pellet was gently resuspended in a buffer containing 10 mM Tris-HCl (pH 7.4), 10 mM NaCl, 3 mM MgCl 2 , and 0.5% Nonidet P-40, allowed to swell on ice for 15 min, and lysed by a Dounce homogenizer (60 -70 strokes) with intermittent inspection of nuclei. The lysate was recentrifuged at 300 ϫ g, and the resulting nuclear pellet was resuspended in 100 ml of buffer containing 20 mM Tris-HCl (pH 8.1), 75 mM NaCl, 0.5 mM EDTA, 1 mM dithiothreitol, and 50% glycerol. In vitro transcription using the nuclear pellet (100 l) was performed in a shaking water bath at 30°C for 30 min in a buffer containing 10 mM Tris-HCl (pH 8.0), 5 mM MgCl 2 , 300 mM KCl, 50 mM EDTA, 1 mM dithiothreitol, 0.5 units of RNasin (Promega, Madison, WI), 0.5 mM CTP, ATP, GTP, and 250 Ci of [␣-32 P]UTP as described previously (24) . Equal amounts (1 g) of purified, denatured full-length HLA-DRA, human ␤-tubulin (ATCC #37855), and linearized pGEM-3z cDNA were vacuum-transferred onto nylon membranes using a slot blot apparatus (Schleicher & Schuell). The membranes were baked and prehybridized as described for Northern blots. The precipitated radiolabeled transcripts (ϳ8 ϫ 10 7 cpm) were resuspended in 2 ml of hybridization buffer containing 50% formamide, 5ϫ SSC, 2.5ϫ Denhardt's solution, 25 mM sodium phosphate buffer (pH 6.5), 0.1% SDS, and 250 mg/ml salmon sperm DNA. Hybridization of radiolabeled transcripts to the nylon membranes was carried out at 45°C for 48 h. The membranes were then washed with 1ϫ SSC, 0.1% SDS for 1 h at 65°C before autoradiography for 72 h at Ϫ80°C.
Electrophoretic Mobility Shift Assay-Nuclear extracts were prepared as described (12) . Oligonucleotides corresponding to the HLA-DRA Y box (5Ј-ATTTTTCTGATTGGCCAAAGAGTA-3Ј) were radiolabeled with [␥- 32 P]ATP and T 4 polynucleotide kinase (New England Biolabs) and purified by Sephadex G-50 columns (Amersham Biosciences AB). Nuclear extracts (10 g) were added to 32 P-labeled oligonucleotides (ϳ20,000 cpm, 0.2 ng) in a buffer containing 4 g of poly(dA⅐dT) (Amersham Biosciences), 10 g of bovine serum albumin, 10 mM Tris-HCl (pH 7.5), 25 mM NaCl, 50 mM MgCl 2 , 1 mM dithiothreitol, 1 mM EDTA, and 5% glycerol (total volume of 20 l). DNA-protein complexes were resolved on 4% non-denaturing polyacrylamide gel electrophoresed at 12 V/cm for 3 h in low ionic strength buffer (0.5ϫ TBE) at 4°C. For supershift assays, the indicated antibody (15 g/ml) was added to the nuclear extracts for 10 min before the addition of radiolabeled probe. To determine the specificity of shifted bands, excess unlabeled oligonucleotide (20 ng) was added directly to the nuclear extracts for 10 min before addition of corresponding radiolabeled probe.
Transfection and CAT Assay-The human HLA-DRA proximal promoter containing the chloramphenicol acetyltransferase (CAT) reporter gene ([Ϫ300].DR␣.CAT) was described previously by Hehlgans and Strominger (25) . Bovine aortic endothelial cells were transfected with each reporter plasmid (50 g) using the calcium phosphate precipitation method. As an internal control for transfection efficiency, pRSV.␤GAL plasmid (10 g) was co-transfected in all experiments. Preliminary results using ␤-galactosidase staining indicate that cellular transfection efficiency was ϳ15%. Cells (60 -70% confluent) were stimulated 24 h after transfection with IFN-␥ (1000 units/ml) in the presence and absence of GSNO (0.2 mM), and cellular extracts were prepared 24 h later using lysis buffer (100 g/ml leupeptin, 50 g/ml aprotinin, 0.1 ml of phenylmethylsulfonyl fluoride, 5 mM EDTA, 5 mM EGTA, 100 mM NaCl, 5 mM Tris-HCl (pH 7.4)) and one freeze-thaw cycle. The cellular extracts were centrifuged at 12,000 ϫ g for 10 min, and the supernatant was subjected to CAT and ␤-galactosidase assay as described previously (26) . The relative CAT activity was calculated as the ratio of CAT to ␤-galactosidase activity. Each experiment was performed three times in duplicate, and all experiments included both positive (highly expressed pSV40.CAT) and negative (promoterless pCAT) controls.
Data Analysis-Band intensities from Northern blots, nuclear run-on assays, and EMSA blots were analyzed densitometrically by the NIH Image program (National Institutes of Health, Bethesda). All values are expressed as mean Ϯ S.E. compared with controls and among separate experiments. Paired and unpaired Student's t tests were employed to determine the significance of changes in absorbance values and densitometric measurements. p values of less than 0.05 were considered significant.
RESULTS

Inhibition of MHC-II Molecules by Nitric
Oxide and Antioxidants-To investigate the immunomodulating role of NO and antioxidants, we treated human vascular endothelial cells with the NO donor, GSNO, and a variety of antioxidants on the cell surface expression of major histocompatibility complex class II (MHC-II) antigen, HLA-DR␣. No constitutive MHC-II expression was detected on the surface of unstimulated endothelial cells by enzyme immunoassay. INF-␥ induced the expression of MHC-II in a concentration-dependent manner. Tumor necrosis factor-␣ (1000 units/ml) had no effect on MHC-II expression but stimulated basal MHC-I expression by 2.6-fold (Fig. 1A) . GSNO (10 -500 M) inhibited IFN-␥-induced MHC-II expression in a concentration-dependent manner. More than 60% inhibition of MHC-II expression was achieved with 500 M GSNO. The basal MHC-I expression was not affected by the NO donor even at highest concentrations, indicating that the observed effects on MHC-II expression were not due to altered cellular viability. (Fig. 1B) . L-Arginine deprivation of the culture medium reduces the inhibitory effect of PDTC (data not shown), indicating a synergistic effect of PDTC and endogenous NO in inhibiting MHC-II expression. These effects were not mediated by cGMP, since the effects on MHC-II expression were not affected by treatment with the membrane-permeable cGMP analogues, dibutyryl cGMP and 8-bromo-cGMP (1 M).
Effect of NO and ROS on HLA-DRA mRNA Expression-IFN-␥ induction of HLA-DRA mRNA expression could be detected as early as 6 h, reaching a maximum level at 12 h (Fig.  2) . We next determined the effect of co-stimulation with GSNO. In the presence of GSNO (0.2 mM) induction of IFN-␥-stimulated HLA-DRA mRNA expression occurred later, at 12 h, and densitometric analysis of autoradiographic bands showed a 6.3-fold decreased steady state HLA-DRA mRNA level at 24 h compared with IFN-␥ stimulation alone. In addition, the steady state expression of HLA-DRA mRNA at 24 h was blunted by NAC and PDTC and, to a lesser extent, by membrane-permeable PEG-SOD (100 units/ml) and PEG-catalase (500 units/ml), suggesting involvement of reactive oxygen species in IFN-␥-induced modulation of HLA-DRA mRNA (Fig. 3) . The decreased steady state HLA-DRA mRNA expression was in agreement with the protein expression as quantified by cell surface enzyme immunoassay. Similar Northern analyses indicate that GSNO (0.5 mM), L-nitroarginine methyl ester (10 M), or H 2 O 2 (150 M) had no effect on the induction of CIITA by IFN-␥. (Fig. 4) . We detected no basal CIITA mRNA expression. IFN-␥ (1000 units/ml) induced CIITA mRNA expression between 2 and 6 h (Fig. 4A) . Like GSNO, co-stimulation with either PDTC, NAC, catalase, or SOD had no effect on IFN-␥-induced CIITA mRNA expression at 24 h (data not shown). L-NAME or H 2 O 2 alone was not sufficient to induce CIITA mRNA expression after 24 h (Fig. 4B) .
IFN-␥ Induces ROS Generation-Inhibition of IFN-␥-induced expression of MHC-II molecules and HLA-DRA mRNA by a variety of antioxidants suggests that cellular responses to IFN-␥ involve ROS. We measured DCF fluorescence in endothelial cells as a marker of oxidative stress to determine the cellular redox status under our experimental conditions ( Fig. 5A ), whereas L-NMA did not (58.1 Ϯ 16.8 units). L-NMA alone had no effect (24 Ϯ 6.9 units). A very high fluorescence signal was achieved by direct stimulation of the cells with exogenous H 2 O 2 (420 Ϯ 121 units, Fig. 5A ). These findings suggest that ROS are involved in cellular response to IFN-␥. DCFH oxidation cannot be attributed to a single reactive oxygen species, because several intermediates during the reduction of hydrogen peroxide (H 2 O 2 ) oxidize DCFH (27) (28) (29) . Therefore, formation of DCF from DCFH should be considered as an index of overall oxidative stress (30) .
Nitric Oxide Inhibits the Transcription of the Human HLA-DRA Gene-To confirm that NO decreases IFN-␥-induced steady state HLA-DRA mRNA levels by transcriptional repression, we performed nuclear run-on experiments using human EC stimulated with IFN-␥ (1000 units/ml) for 12 or 24 h in the presence or absence of NO (GSNO, 0.2 mM, Fig. 6 ). In unstimulated EC there was no basal HLA-DRA transcriptional activity. IFN-␥ (1000 units/ml)-induced HLA-DRA gene transcription was detectable after 12 h and maximal after 24 h. Preliminary studies using different amounts of radiolabeled RNA transcripts demonstrate that under our experimental conditions, hybridization was linear and not saturable. Co-treatment with GSNO demonstrated a transcriptional effect of NO on HLA-DRA expression by repressing HLA-DRA transcription. Specificity was established by lack of hybridization to the insertless vector, pGEM. Transcription of the ␤-tubulin gene served as an internal control. .DR␣.CAT, was used in transient transfection studies. These studies were performed with bovine rather than human endothelial cells due to higher transfection efficiency with bovine cells using the calcium phosphate precipitation method (12 versus Ͻ2%). The promoterless pCAT produced essentially no relative CAT activity (50 Ϯ 40). The highly expressed pSV40.CAT containing the SV40 early promoter exhibited a high level of relative CAT activity (1400 Ϯ 260) which is a 7.46 Ϯ 260-fold induction compared with [Ϫ300].DR␣.CAT (Basal, Fig. 7) . Treatment of the cells with IFN-␥ (1000 units/ml) for 12 h caused a 4.1 Ϯ 0.3-fold increase in relative CAT activity compared with basal activity. Co-stimulation with GSNO significantly inhibited the IFN-␥ effect (only 1.4 Ϯ 0.16-fold induction). Interestingly, we found that H 2 O 2 can directly induce the promoter activity 5.7 Ϯ 0.6-fold, whereas inactivation of H 2 O 2 by catalase completely abolished IFN-␥ induced promoter activity (0.7 Ϯ 0.26-fold), suggesting that H 2 O 2 is a necessary mediator of IFN-␥. As shown above, H 2 O 2 by itself is not sufficient to induce MHC-II expression (Fig. 1B) , although disrupting the cellular redox homeostasis (Fig. 5A) . SOD (100 units/ml) also inhibited IFN-␥-induced promoter activity (3.0 Ϯ 0.4-fold induction). Inhibition of endogenous NO by L-NMA (1 mM) increased both basal and IFN-␥-stimulated HLA-DRA minimal promoter activity (4.1 Ϯ 0.5-and 9.5 Ϯ 1.2-fold, respectively).
To localize the site of inhibition on the HLA-DRA promoter by NO, we analyzed the DNA binding activity of NF-Y under cytokine stimulation and under co-stimulation with nitric oxide. This transcription factor was of particular interest because it recognizes the CCAAT box, a redox-sensitive motif within the HLA-DRA promoter, with high affinity and specificity (31, 32) . The CCAAT box is necessary for HLA-DRA gene transcription. To determine whether exogenous NO inhibits NF-Y DNA bind- ing activity, we performed EMSA using radiolabeled oligonucleotide corresponding to the Y box in the HLA-DRA promoter (Fig. 8A) . We found a significant decrease in NF-Y binding activity when cells were treated with GSNO (0.5 mM) in addition to IFN-␥ (Fig. 8A, lane 3) . Stimulation with IFN-␥ alone (Fig. 8, lanes 2, 4, and 5 ) seems to increase DNA binding, but this effect was not significant when compared with unstimulated cells (lane 1). The shifted complexes were specific for NF-Y since they were supershifted in the presence of an antibody to the A subunit of NF-Y (Fig. 8, lane 5) and disappeared with excess unlabeled oligonucleotide (lane 4). To investigate further the role of NF-Y in regulating the effect of NO in MHC-II gene transcription, we tested whether the altered DNA binding activity may be explained by nuclear NF-Y expression. Although IFN-␥ alone did not alter the expression of the A and B subunits of NF-Y, we found that co-treatment with GSNO reduced the amount of both NF-YA and NF-YB (Fig. 8B) . DISCUSSION We have shown that the induction of HLA-DRA gene transcription by IFN-␥ is dependent upon the generation of ROS in vascular endothelial cells, in part by activating Y box transactivating proteins. These findings are consistent with studies showing that IFN-␥ stimulates the production of ROS in vascular endothelial cells (22) and that the Y box motif is an oxidant-sensitive cis-acting element (20) . The ability of antioxidants such as NAC, PDTC, PEG-conjugated catalase, and SOD to inhibit IFN-␥-induced HLA-DRA protein and mRNA expression suggests that ROS are required for IFN-␥-induced HLA-DRA gene transcription. Indeed, we found that H 2 O 2 can directly stimulate the HLA-DRA minimal promoter. However, neither H 2 O 2 nor L-NMA, alone or in combination, could induce the expression of HLA-DRA, indicating that ROS production is necessary but, by itself, not sufficient for HLA-DRA gene transcription.
Most interesting, NO was able to inhibit IFN-␥-induced HLA-DRA gene transcription. Inhibition of endogenous NO by L-NMA increased both basal and IFN-␥-stimulated HLA-DRA minimal promoter activity. Endothelium-derived NO is an important endogenous modulator of vascular tone, platelet aggregation, and vascular smooth muscle proliferation (33) (34) (35) (36) . For example, supplementation with L-arginine, the precursor of NO, to the diets of cholesterol-fed rabbits leads to inhibition of endothelium-leukocyte interaction and attenuation of atherosclerotic lesions (37) . Inhibition in endogenous NO with N -monomethyl-L-arginine results in enhanced leukocyte adhesiveness to the vessel wall (38) . Indeed, we have shown recently (39) that exogenous NO can regulate leukocyte homeostasis in the vessel wall by inhibiting the release of soluble cytokines such as IL-6 and IL-8 and attenuating the expression of various cell surface adhesion molecules. The mechanism underlying the effects of NO on cytokine-induced VCAM-1 expression is via the inhibition of NF-B. This is similar to the effects of antioxidants, which also inhibit cytokine-induced NF-B activation and VCAM-1 expression (40, 41) . Thus, NO appears to perform similar functions as antioxidants with respect to inhibiting cytokine-induced endothelial cell activation. Our observations that NO inhibits IFN-␥-induced HLA-DRA promoter activity and inhibition of NO synthase increased HLA-DRA promoter activity suggest a direct effect of IFN-␥ on eNOS. This is supported by previous studies (42, 43) showing that exposure of endothelial cells to cytokines, among them IFN-␥, reduced eNOS expression. However, we did not observe changes in eNOS expression upon stimulation with IFN-␥. The finding that L-NMA was able to increase further IFN-␥-induced activity of the HLA-DRA promoter construct suggests that IFN-␥ does not significantly alter eNOS function but inhibits physiological functions of NO, probably by generating superoxide which rapidly reacts with NO (44) .
The induction of MHC class II gene transcription by IFN-␥ occurs relatively slowly and is mediated by the MHC class II transactivator (CIITA), a non-DNA-binding protein, and depends on the presence of the transcription factors STAT1␣ (45) and IRF-1 (46) . STAT1␣ induces transcription of CIITA both by direct binding to CIITA promoter and by inducing transcription of IRF-1. CIITA is both essential and sufficient for MHC-II expression (47) . In addition, stereo-specific alignment of the X and Y box motif is required for the MHC-II promoter response to IFN-␥ (48 -50). Although CIITA does not directly bind to enhancer elements in the MHC-II genes, its activation is necessary for the coordinate binding of W, X, and Y box transactivating proteins (51) .
In our study, NO or antioxidants inhibited expression and binding of Y box-binding proteins. Furthermore, electrophoretic mobility shift assays showed that co-stimulation of endothelial cells with NO or antioxidants also resulted in inhibition of STAT1␣ induction (data not shown). However, we observed no effect of NO on IRF-1 activity or CIITA induction in IFN-␥-stimulated cells. This was in contrast to data published previously by Kielar et al. (52) who found that NO inhibited IFN-␥-induced increases in CIITA gene transcription in murine macrophages. A possible explanation for this discrepancy may due to differences in cell type and species. For example, macrophages constitutively express MHC-II, whereas endothelial cells do not express MHC-II molecules under basal conditions. A possible explanation for the inhibitory effect of NO on the IFN-␥ pathway, although without affecting CIITA expression, could be the finding in activated macrophages that nitration of tyrosine residues in STAT1␣ by NO inhibits IFN-␥-induced phosphorylation of STAT1␣ (53) . It is known that STAT1␣ can be specifically activated by oxidative stress (54) , and we demonstrated ROS upon stimulation with IFN-␥, and therefore it is not surprising that antioxidants affect STAT1␣ activity. But again, these effects were only weak compared with the effect on Y box transcription factors.
Inhibition of endogenous NO synthesis by L-NMA did not affect IFN-␥-induced MHC-II expression in our study, whereas we observed a 4-fold induction of the HLA-DRA promoter by NO, even in the absence of IFN-␥. Moreover, L-NMA further increased IFN-␥-induced promoter activity. Taken together, these findings support our observation that elements in the MHC-II promoter are required for the NO effects on MHC-II expression. Within the HLA-DRA promoter, the Y box motif is of considerable interest for its ability to bind oxidant-sensitive transcription factors (21) . The Y box contains an inverted CCAAT motif and plays a role in eukaryotic redox signaling (20) . A recent study demonstrated that the prokaryotic oxyRresponse element, which is found in the promoters of many bacterial genes coding for peroxidase-inactivating enzymes such as catalase (katG), is highly homologous to the eukaryotic Y box cis-acting element (20) . The oxyR-response element can function as a redox-dependent transcriptional enhancer in murine cells by interacting with a member of the Y box family of DNA-and RNA-binding proteins, YB-1 (20) . Thus, although the MHC-II genes lack oxidant-sensitive B and activated protein-1 sites, which are present in many pro-inflammatory genes including MHC-I, they could still be responsive to ROS production through their Y box cis-acting elements.
Recently, the ROS-mediated regulation of the Escherichia coli OxyR transcription factor could be demonstrated by crystal structure analysis (55) . Reversible intramolecular disulfide bond-mediated changes in the protein structure appear to be responsible for its activity. The OxyR protein is activated in response to H 2 O 2 and induces transcription of genes that protect the bacterium against oxidative stress (56) . We cannot rule out the possibility that functional activities such as proteinprotein interactions of the Y box proteins or their transcriptional activation may be affected by co-stimulation of IFN-␥-stimulated cell, thus inhibiting MHC-II expression. Indeed, our findings that H 2 O 2 by itself induced HLA-DRA promoter activity and antioxidants such as catalase completely inhibited IFN-␥ induced promoter activity support the postulated function of NF-Y as an oxidant-sensitive transcription factor. In conclusion, we find that the Y box motif is an oxidant-sensitive cis-acting element in the HLA-DRA promoter that mediates anti-inflammatory responses of NO in vascular endothelial cells. The immunomodulating effect of NO on vascular wall cells is consistent with its complex role in regulating inflammatory responses in the vascular wall.
